LPL Financial
RCUS icon

LPL Financial’s Arcus Biosciences RCUS Stock Holding History

LPL Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494K Sell
22,860
-1,351
-6% -$29.2K ﹤0.01% 4762
2025
Q4 		$577K Buy
24,211
+1,302
+6% +$26.6K ﹤0.01% 4590
2025
Q3 		$312K Buy
22,909
+355
+2% +$3.69K ﹤0.01% 5023
2025
Q2 		$184K Buy
22,554
+4,120
+22% +$35.2K ﹤0.01% 5119
2025
Q1 		$145K Buy
18,434
+4,900
+36% +$56.8K ﹤0.01% 4952
2024
Q4 		$202K Buy
13,534
+175
+1% +$2.86K ﹤0.01% 4814
2024
Q3 		$204K Buy
13,359
+161
+1% +$2.54K ﹤0.01% 4714
2024
Q2 		$201K Buy
13,198
+3,135
+31% +$50.6K ﹤0.01% 4571
2024
Q1 		$190K Buy
+10,063
New +$174K ﹤0.01% 4521

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

LPL Financial's RCUS Position: Q1 2026 in Review

LPL Financial reduced its Arcus Biosciences (RCUS) stake by 5.6% in Q1 2026, selling an estimated $29.2K and leaving 22,860 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #4762.

LPL Financial first reported a position in RCUS in Q1 2024 and has held it in 9 quarters since. The position peaked at $577K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • LPL Financial held 22,860 shares of Arcus Biosciences worth $494K as of Q1 2026.
  • LPL Financial sold 1,351 Arcus Biosciences shares in Q1 2026, an estimated $29.2K.
  • Arcus Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4762 holding.
  • LPL Financial first reported a position in Arcus Biosciences in Q1 2024 and has held it in 9 quarters since.
  • LPL Financial's Arcus Biosciences position peaked at $577K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.